[Form 4] Kindly MD, Inc. Insider Trading Activity
Mark W. Yusko, a director of Kindly MD, Inc. (NAKA), reported an acquisition of 112,781 restricted stock units (RSUs) on 09/22/2025. The filing shows these RSUs were granted at a price of $0 and that the reporting person will beneficially own 2,212,781 shares following the grant. The RSUs vest on August 15, 2026 and are subject to the reporting personontinuing service on the companyoard through that vesting date. The Form 4 was signed and submitted by an attorney-in-fact on behalf of the reporting person.
Mark W. Yusko, direttore di Kindly MD, Inc. (NAKA), ha riportato un'acquisizione di 112.781 unità di azioni vincolate (RSU) il 22/09/2025. La pratica mostra che queste RSU sono state assegnate a un prezzo di $0 e che la persona che segnala sarà intestataria beneficiaria di 2.212.781 azioni dopo l'assegnazione. Le RSU maturano il 15 agosto 2026 e sono soggette a un proseguimento di servizio da parte della persona che segnala sul consiglio della società fino a tale data di maturazione. Il modulo 4 è stato firmato e depositato da un procuratore fiduciario per conto della persona che segnala.
Mark W. Yusko, director de Kindly MD, Inc. (NAKA), informó la adquisición de 112,781 unidades de acciones restringidas (RSU) el 22/09/2025. El anuncio muestra que estas RSU fueron otorgadas a un precio de $0 y que la persona reportante poseerá 2,212,781 acciones de forma beneficiosa tras la adjudicación. Las RSU vencen el 15 de agosto de 2026 y están sujetas a que la persona reportante continúe prestando servicios a la empresa hasta esa fecha de vencimiento. El Formulario 4 fue firmado y presentado por un apoderado en nombre de la persona reportante.
Mark W. Yusko는 Kindly MD, Inc. (NAKA)의 이사로서 제한 주식 단위(RSU) 112,781를 2025년 9월 22일에 취득했다고 보고했습니다. 서류에 따르면 이 RSU는 $0의 가격으로 서여부되었고 보고 당사자는 부여 이후 2,212,781주의 유익한 소유권을 가질 예정입니다. RSU는 2026년 8월 15일에 vest되며, 그 만기일까지 회사 이사회에 대한 보고 당사자의 지속적인 근무 의무가 있습니다. Form 4는 보고 당사자를 대신하여 대리인이 서명하고 제출했습니다.
Mark W. Yusko, administrateur de Kindly MD, Inc. (NAKA), a signalé l'acquisition de 112 781 unités d'actions restreintes (RSU) le 22/09/2025. Le dépôt indique que ces RSU ont été attribuées à un prix de $0 et que la personne déclarante détiendra 2 212 781 actions de manière bénéficiaire après l’attribution. Les RSU vestent le 15 août 2026 et sont soumises à la poursuite du service par la personne déclarante au conseil d'administration de l’entreprise jusqu’à cette date d’acquisition. Le Formulaire 4 a été signé et soumis par un procureur au nom de la personne déclarante.
Mark W. Yusko, Direktor von Kindly MD, Inc. (NAKA), meldete den Erwerb von 112.781 Restricted Stock Units (RSUs) am 22.09.2025. Die Einreichung zeigt, dass diese RSUs zu einem Preis von $0 gewährt wurden und dass die meldende Person nach der Gewährung 2.212.781 Aktien vorteilhaft halten wird. Die RSUs vesten am 15. August 2026 und unterliegen der fortgesetzten Dienstleistung der meldenden Person im Vorstand des Unternehmens bis zu diesem Vesting-Datum. Das Form 4 wurde von einem Bevollmächtigten im Namen der meldenden Person unterzeichnet und eingereicht.
مارك و. يوسكو، مدير لدى Kindly MD, Inc. (NAKA)، أبلغ عن اكتساب 112,781 وحدة أسهم مقيدة (RSUs) في 22/09/2025. تُظهر الافصاح أن هذه RSUs مُنحت بسعر $0 وأن الشخص المبلغ سيصبح مالكاً مستفيداً لــ 2,212,781 سهماً بعد المنحة. تستحق RSUs في 15 أغسطس 2026 وتخضع لاستمرار خدمة الشخص المبلغ في مجلس إدارة الشركة حتى تاريخ الاستحقاق ذلك. تم توقيع وتقديم النموذج 4 بواسطة نائب مفوض نيابة عن الشخص المبلغ.
Mark W. Yusko,Kindly MD, Inc. (NAKA) 的董事,已于 2025/09/22 报告获得了 112,781 份受限股票单位(RSU)。文件显示这些 RSU 的授予价格为 $0,且报告人将在授予后拥有 2,212,781 股 的实益所有权。RSU 将在 2026-08-15 到期并且在该受限日期前,报告人需继续在公司董事会任职。Form 4 由代理授权人代表报告人签署并提交。
- Director alignment: Grant of 112,781 RSUs aligns the reporting personinancial incentives with long‑term shareholder value
- Increased disclosed ownership: Beneficial ownership rises to 2,212,781 shares, improving transparency of insider holdings
- Not immediately vested: RSUs vest on August 15, 2026 and require continued board service through that date
- Limited disclosure: Filing does not specify total outstanding shares, settlement method for RSUs, or board approval context
Insights
TL;DR: Director received time‑based RSUs that align long‑term incentives with shareholders but vesting requires continued board service.
The grant of 112,781 RSUs to a director is a standard compensation mechanism to align director incentives with shareholder value over time. Because the units vest on a specified future date only if board service continues through August 15, 2026, the award ties retention and long‑term performance to the companyquity. The filing provides clear disclosure of the grant date, grant amount, and vesting condition but does not disclose the rationale for the award or any board approval details; those would appear in proxy or compensation disclosures.
TL;DR: The transaction increases the directoreneficial stake to 2,212,781 shares via time‑vesting RSUs granted at no cash cost.
The Form 4 reports an in‑kind equity award (RSUs) recorded at $0 per unit and increases reported beneficial ownership to 2,212,781 shares. These RSUs are not immediately exercisable and carry a vesting condition tied to continued board service through August 15, 2026, so any market impact depends on future vesting and potential settlement terms. The disclosure is limited to the grant mechanics; no information on dilution, total share count, or expected settlement method is provided in this filing.
Mark W. Yusko, direttore di Kindly MD, Inc. (NAKA), ha riportato un'acquisizione di 112.781 unità di azioni vincolate (RSU) il 22/09/2025. La pratica mostra che queste RSU sono state assegnate a un prezzo di $0 e che la persona che segnala sarà intestataria beneficiaria di 2.212.781 azioni dopo l'assegnazione. Le RSU maturano il 15 agosto 2026 e sono soggette a un proseguimento di servizio da parte della persona che segnala sul consiglio della società fino a tale data di maturazione. Il modulo 4 è stato firmato e depositato da un procuratore fiduciario per conto della persona che segnala.
Mark W. Yusko, director de Kindly MD, Inc. (NAKA), informó la adquisición de 112,781 unidades de acciones restringidas (RSU) el 22/09/2025. El anuncio muestra que estas RSU fueron otorgadas a un precio de $0 y que la persona reportante poseerá 2,212,781 acciones de forma beneficiosa tras la adjudicación. Las RSU vencen el 15 de agosto de 2026 y están sujetas a que la persona reportante continúe prestando servicios a la empresa hasta esa fecha de vencimiento. El Formulario 4 fue firmado y presentado por un apoderado en nombre de la persona reportante.
Mark W. Yusko는 Kindly MD, Inc. (NAKA)의 이사로서 제한 주식 단위(RSU) 112,781를 2025년 9월 22일에 취득했다고 보고했습니다. 서류에 따르면 이 RSU는 $0의 가격으로 서여부되었고 보고 당사자는 부여 이후 2,212,781주의 유익한 소유권을 가질 예정입니다. RSU는 2026년 8월 15일에 vest되며, 그 만기일까지 회사 이사회에 대한 보고 당사자의 지속적인 근무 의무가 있습니다. Form 4는 보고 당사자를 대신하여 대리인이 서명하고 제출했습니다.
Mark W. Yusko, administrateur de Kindly MD, Inc. (NAKA), a signalé l'acquisition de 112 781 unités d'actions restreintes (RSU) le 22/09/2025. Le dépôt indique que ces RSU ont été attribuées à un prix de $0 et que la personne déclarante détiendra 2 212 781 actions de manière bénéficiaire après l’attribution. Les RSU vestent le 15 août 2026 et sont soumises à la poursuite du service par la personne déclarante au conseil d'administration de l’entreprise jusqu’à cette date d’acquisition. Le Formulaire 4 a été signé et soumis par un procureur au nom de la personne déclarante.
Mark W. Yusko, Direktor von Kindly MD, Inc. (NAKA), meldete den Erwerb von 112.781 Restricted Stock Units (RSUs) am 22.09.2025. Die Einreichung zeigt, dass diese RSUs zu einem Preis von $0 gewährt wurden und dass die meldende Person nach der Gewährung 2.212.781 Aktien vorteilhaft halten wird. Die RSUs vesten am 15. August 2026 und unterliegen der fortgesetzten Dienstleistung der meldenden Person im Vorstand des Unternehmens bis zu diesem Vesting-Datum. Das Form 4 wurde von einem Bevollmächtigten im Namen der meldenden Person unterzeichnet und eingereicht.